Figure 4From: Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT Median lipid values over the course of the study, with lines within shaded areas showing NCEP cut-offs. Back to article page